Novartis and Argo Biopharma are no strangers to collaboration, having initiated their partnership back in January 2024 with a significant investment totaling up to $4.165 billion across two RNAi agreements aimed at tackling cardiovascular diseases. Fast forward to the present day, and the two companies are strengthening their ties with a fresh multibillion-dollar commitment that […]
Novartis, a prominent pharmaceutical company based in Switzerland with its U.S. headquarters in East Hanover, is embarking on a significant restructuring journey. In response to evolving market demands and a commitment to enhancing operational efficiency, Novartis has announced plans for further job cuts at its East Hanover base as part of a broader global restructuring […]
Novartis, a global leader in healthcare, has announced its acquisition of Tourmaline Bio, a biotech company at the forefront of developing cutting-edge treatments for heart disease. The deal, valued at $1.5 billion, signifies Novartis’ strategic move to bolster its cardiovascular portfolio and tap into the immense potential of Tourmaline Bio’s innovative therapies. Tourmaline Bio’s flagship […]
BioArctic AB, a Swedish biopharma company, has partnered with Novartis Pharma AG to develop a potential treatment using BioArctic’s BrainTransporter technology alongside an undisclosed target in neurodegeneration. The agreement includes an initial research collaboration with a $30 million upfront payment to BioArctic. Novartis has the option to license any drug candidate resulting from the collaboration, […]
In a recent development, Eli Lilly reported positive outcomes from its monarchE study, showcasing the potential of their drug Verzenio in extending the survival of individuals with early-stage breast cancer. The study, initiated in 2017 and involving over 5,600 adults with high-risk breast cancer that was hormone receptor-positive but HER2-negative, demonstrated that combining Verzenio with […]
Atropos Health, a company specializing in real-world data analysis, has recently joined forces with the pharmaceutical giant Novartis to enhance the identification of individuals suffering from the rare blood disorder paroxysmal nocturnal hemoglobinuria (PNH) who have not yet received a diagnosis. PNH is a condition affecting hematopoietic stem cells, where the immune system mistakenly attacks […]
Gauging the performance of a company involves a comprehensive methodology that includes peer comparison, a technique widely appreciated by analysts and investors alike. A company’s peer group comprises other companies sharing similar attributes such as industry, size, age, and financial structure. Acquiring an understanding of a company’s peer group can be achieved through several means, […]
